top of page

Reinventing life sciences leadership: What does it take?
Life Sciences Leaders Forum
January 23, 2023, 9 am to 7 pm ET, Boston

Today’s changing and challenging life sciences environment creates an imperative for leaders: We need to reinvent ourselves to succeed.

Consider the kind of leadership we need to deliver. Not long ago, it was often science leadership, in a science enterprise.

Science, and biotech innovation, are still at the heart of the work. However, whether as CEO, or head of R&D, or of the commercial functions, or other areas, we as leaders need to master dramatically greater complexity, and need much broader bandwidth to do so. These challenges were at the heart of the Forum on January 23rd, 2023.

Agenda topics included:

  1. Can we reinvent perceptions of our sector?

  2. Gen Z: What should we know? What should we do?

  3. How should we recreate the workplace for high performance?

  4. The economics of innovation and health: What are the best perspectives and priorities for success, in stressful conditions?

  5. Reinventing ourselves as leaders: What leadership qualities do we  need to drive high performance for the next five years?

To view the agenda, please click here.



  • Kate Cronin, Chief Brand Officer, Moderna

  • Christian Desrosiers, Founder, Friendpass

  • Paul Hastings, President & CEO, Nkarta Therapeutics

  • Kevin Hershfield, COO, TearClear

  • Dale Keshishian, Founder & CEO, HealthWorks Academy

  • Nancy Lurker, CEO & Board Director, EyePoint Pharmaceuticals

  • Aaron Mertz, Director, The Aspen Institute

  • John Penrose, CEO, Leading Indicator Systems

  • Craig Tooman, President & CEO, Silence Therapeutics

  • Charles Wohlforth, Author


To view the agenda, please click here.



Foley & Lardner LLP
bottom of page